GRI
GRI Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.88
+25.76%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-80.7%
Return on equity
-72.9%
Return on assets
-80.6%
Return on invested capital
0.00x
Asset turnover
-$11.8M
Cash from operations
$5.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026